Thank you!
Your support is sustaining the future of local news in our communities.

Study focus: treatment of dementia

Of all the diseases that afflict us, dementia is one of the most terrifying because we see it coming and it is inexorable. It takes the mind but leaves the body. We have theories about what causes Alzheimer’s disease — tangles of a protein called beta-amyloid and over-expression of another protein called tau. These proteins in altered forms were thought to be a cause but removing them from most of the cells in the brain using monoclonal antibodies, did not improve symptoms by much. Perhaps the intervention was too late. Both proteins are probably involved but neither has been a fertile source of treatments, and most clinical trials have failed.

I worked in a Department of Pathology and Cell Biology at Columbia University Irving Medical Center where there are basic scientists and pathologists. A pathologist friend lamented the lack of progress for dementia and Parkinsonism as professionally embarrassing. Heart disease, inflammatory diseases, diabetes, cancer, and other conditions have fared better; there are new and effective treatments to extend life and restore independence, most stemming from basic research in cell biology.

There are many cures offered on the internet, but most are wishful thinking or fraud. One study bears watching: it suggested that vaccination for shingles, a painful rash caused by lingering chickenpox virus (Herpes zoster), reduces the number of cases of dementia in older people. Herpes zoster is a neurotropic virus, that selectively infects nerve cells, whose connections, or synapses in the parts of the brain dedicated to memory are the cellular basis of memory. Each nerve cell has 10,000 or more connections with other neurons.

The study in question hangs on a decision made by the UK’s National Health Service after the Shingrix vaccine became available in 2013. NHS decided to give the vaccine to people in Wales born after Sept. 1, 1933, but not to those born one week before. The two groups, in Wales, 80 years old in 2013, were otherwise identical.Each part of the study had thousands of patients.

The chickenpox vaccine reduced the number of people who became demented over the next 7 years by about 20%. The paper is from scientists at Stanford and several Swiss and German universities. It is tough statistical sledding to read but the data are serious. Twenty percent of patients is too few to be confident, but too many to ignore. See below for the reference.

There are many cures offered on the internet, but most are wishful thinking or fraud.

This experiment has been repeated by combining other data from England and Wales. This type of analysis, involving thousands of patient records, has become possible by keeping records in searchable databases. Other versions of the chickenpox vaccine experiment use a more effective vaccine that became available in 2023. Does the newer vaccine protect better than 20%?Does a vaccine applied when people are younger, or given repeatedly, slow the onset of dementia even better?

Think of a slow acting virus that destroys or inhibits neurons or the synapses involved in memory.It could be Herpes zoster lingering from childhood chickenpox or another virus. The vaccine could induce antibodies and T cells that would stop the progression of the slow virus and stave off dementia.A viral cause of dementia would be extraordinary. And actionable.

A second discovery that may be helpful is the effect of weight loss drugs like Wegovy on dementia. These drugs may also help a number of problems including drug addiction and alcohol abuse.

There are several ways to study the effect of these remarkable drugs. One takes advantage of the fact that loss of brain volume is amarker of Alzheimer’s disease. As the disease progresses damage spreads through the brain and it shrinks, which can be observed by magnetic resonance imaging.

One placebo-controlled trial analyzed 204 patients with mild Alzheimer’s disease at 24 clinics in the United Kingdom. Before the study began, all patients had magnetic resonance imaging of their brains to evaluate structure and volume. Half were given a daily injection of 1.8 milligrams of liraglutide/day, a drug used in weight loss and diabetes, while an equal number received a placebo.Those who received liraglutide lost less brain volume (about 50%) than untreated patients. Cognitive testing was done at 0, 24, and 52 weeks and researchers found that patients who received liraglutide hada slower decline in cognitive function — halfthat of untreated patients. They also said they felt better.

Like the Herpes zoster study the results are not conclusive but at this stage we are looking for a new approach, not miracles. Liraglutide and other GLP-1 analogues are licensed for obesity and diabetes, so its path to treatment for Alzheimer’sand other dementias could be relatively swift.

Two independent and larger phase 3 trials are underway, with results due at the end of 2025. If the results are correct, oneprediction would be that people who had been on weight loss drugs should not be entering memory care units. That analysis is difficult, and some of the databases are proprietary, but we will follow these experiments.


To join a study, go to clinicaltrials.gov. Use the search function.


A natural experiment on the effect of herpes zoster vaccination on dementia

https://doi.org/10.1038/s41586-025-08800-x


Dementia symptoms and areas of the brain

https://www.alzheimers.org.uk/about-dementia/stage...


Evaluation of Novel GLP-1 analogue in the treatment of Alzheimer’s disease

Authors: Paul Edison et al.

Volume: Volume20, IssueS6

DOI: https://doi.org/10.1002/alz.089799

Published: 09 January 2025

PDF: https://alz-journals.onlinelibrary.wiley.com/doi/p....…

Liraglutide is a glucagon-like peptide-1 (GLP-1) analogue licensed for the treatment of type 2 diabetes mellitus (T2DM). Preclinical evidence in transgenic models of Alzheimer’s disease suggests that liraglutide exerts neuroprotective effects by reducing amyloid oligomers.


Richard Kessin, PhD is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.Richard Kessin, PhD is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.

The views expressed here are not necessarily those of The Millerton News and The News does not support or oppose candidates for public office.

Latest News

Tenmile Distillery is making history the old-fashioned way

Cheers! The Revolutionary Whisky Series at Ten Mile Distillery, each named for a significant battle of the American Revolution, celebrates America at 250.

D.H. Callahan

In December 2024, the U.S. Alcohol and Tobacco Tax and Trade Bureau officially established the Standard of Identity for American Single Malt Whisky. It was the first new classification in more than half a century, creating new possibilities for American distillers. One of the distilleries taking advantage of this new landscape is Wassaic’s Tenmile Distillery. It is well positioned to make history because Tenmile has always honored traditional whiskey-making practices.

Single malts are often associated with Scotch whisky. Perhaps that’s why, years before the new standard was adopted, Tenmile hired Shane Fraser, a Scottish master distiller with 30 years of experience at some of Scotland’s most prestigious distilleries. Fraser began designing the distillery from the ground up. Alongside owner and general manager Joel LeVangia, he emphasized time-honored traditions, favoring hands-on craftsmanship over the increasingly automated methods used by larger producers. When it comes to making the best whisky possible, Tenmile believes in learning from the past. That philosophy extends beyond the distilling process.

Keep ReadingShow less

The magic of Belinda Sinclair

The magic of Belinda Sinclair

Belinda Sinclair

Dean Chamberlain
Sinclair’s show explores the ways women have been practicing forms of magic for centuries, and there is plenty of history to tell.

Belinda Sinclair is the kind of magician who impresses people who don’t like magic. Her tricks are mind-boggling. Her stories are captivating. And if she picks you to write your name on a card, get ready to be wowed. Repeat attendees of her shows, of which there are many, take almost as much delight in watching new jaws drop as they do in seeing an illusion reach its astonishing conclusion.

Since the summer of 2025, Sinclair has been baffling local audiences at the Hughes Memorial Library in West Cornwall, but her magical run comes to a close at the end of August.

Keep ReadingShow less

“Nixon in China” comes to Tanglewood

“Nixon in China” comes to Tanglewood

Renée Fleming, Andris Nelsons and Thomas Hampson.

Hilary Scott

On Friday, July 17 at 8 p.m. in the Koussevitzky Music Shed at Tanglewood, two of the greatest American voices of their generation, soprano Renée Fleming and baritone Thomas Hampson, join Music Director Andris Nelsons and the Boston Symphony Orchestra in a performance of excerpts from John Adams’ groundbreaking opera “Nixon in China.” The piece, performed earlier this year in Boston and at Carnegie Hall in New York City, is a highlight of a program that also includes “Meditations on Grace” (2024) by BSO Composer Chair Carlos Simon, and the melodic and technically demanding Violin Concerto by Samuel Barber.

Fleming is internationally celebrated for her vocal and dramatic artistry, as well as for her advocacy for the powerful impact of the creative arts in health. Hampson has long been recognized as one of the most innovative musicians of our time and has received countless international honors for his singular artistry and cultural leadership. Both performed in “Nixon in China” earlier this year at the Paris Opera under the baton of Kent Nagano.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Local playwright revisits Revolutionary moment in “Rebel Town”

The cast and crew of “Rebeltown: The Musical.”

Jack Sheedy

John Alan Segalla was working in Boston a few years ago, giving historic tours at the site of the Boston Tea Party. Now, as America celebrates 250 years as a nation, the Canaan native is about to debut a new version of his original musical, “Rebel Town,” inspired largely by the Boston Tea Party, the protest that helped launch the American Revolution.

“It wasn’t until I got to Boston and learned the Tea Party story that I fell in love with this moment in history, and I saw the story as wildly compelling and very important, and really a story that was very misunderstood, mistaught in schools,” Segalla said at a recent rehearsal in Stockbridge, Massachusetts, ahead of the show’s July 10 opening.

Keep ReadingShow less
An invitation to paint a community mural in Torrington

Community mural design by Macayla Muzzulin will be painted by volunteers on July 11 in Franklin Plaza in Torrington.

Provided

From 10 a.m. to 4 p.m. on Saturday, July 11, Five Points Arts in Torrington will host a community mural project celebrating the nation’s 250th anniversary. Volunteers of every age and artistic ability are invited to help paint a 20-by-6-foot mural designed by artist Macayla Muzzulin. The mural will be completed in one day, transformed from a numbered outline into a permanent public artwork along the river in downtown Torrington.

“We firmly believe art is for everyone,” said Five Points founder and executive director, Judith McElhone. “It’s so great to be able to do this with such talent, and with Launchpad artists, volunteers and staff there to help.”

Keep ReadingShow less
Free sinonó concert launches Wassaic Project’s music season

Gridley Chapel at The Wassaic Project.

Lucia Iandolo

The Wassaic Project will host its first musical act of the season at the Gridley Chapel on Saturday, July 11. The event is free and was made possible with funding from a grant from the New York State Council on the Arts.

Officially opening in October, the Chapel will come alive with the sounds of sinonó, a trio featuring vocalist and composer isabel crespo pardo, cellist Lester St. Louis and bassist Henry Fraser. The group draws on Latin American folk and classical chamber music to create what it calls “poemsongs.”

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.